KRONOS BIO INC's ticker is KRON and the CUSIP is 50107A104. A total of 82 filers reported holding KRONOS BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | -25.0% | 16,128 | 0.0% | 0.00% | – |
| Q2 2023 | $28 | -51.7% | 16,128 | -59.4% | 0.00% | – |
| Q1 2023 | $58 | +31.8% | 39,687 | +46.7% | 0.00% | – |
| Q4 2022 | $44 | -99.9% | 27,053 | +51.5% | 0.00% | – |
| Q3 2022 | $60,000 | -16.7% | 17,853 | -10.2% | 0.00% | – |
| Q2 2022 | $72,000 | -6.5% | 19,877 | +93.6% | 0.00% | – |
| Q1 2022 | $77,000 | – | 10,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,765,314 | $4,037,358 | 5.52% |
| Omega Fund Management, LLC | 3,818,283 | $5,574,693 | 3.64% |
| Nextech Invest Ltd. | 1,451,537 | $2,119,244 | 0.88% |
| Wildcat Capital Management, LLC | 1,297,959 | $1,895,020 | 0.70% |
| Privium Fund Management (UK) Ltd | 292,182 | $455,804 | 0.36% |
| CM Management, LLC | 180,000 | $263 | 0.31% |
| Artal Group S.A. | 1,542,954 | $2,253 | 0.13% |
| Alphabet Inc. | 1,438,232 | $2,099,819 | 0.12% |
| Perceptive Advisors | 1,752,745 | $2,558,131 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 406,362 | $593 | 0.06% |